Martin Lehr
Founder at CONTEXT THERAPEUTICS INC.
Net worth: 1 M $ as of 2024-04-29
Martin Lehr active positions
Companies | Position | Start | End |
---|---|---|---|
CONTEXT THERAPEUTICS INC. | Director/Board Member | 2015-03-31 | - |
Chief Executive Officer | 2015-03-31 | - | |
Founder | 2015-03-31 | - | |
President | 2015-03-31 | - | |
Context Therapeutics LLC
Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Context Therapeutics LLC develops novel medicines for hormone responsive cancers. The company was founded by Martin Lehr in 2016 and is headquartered in Philadelphia, PA. | Director/Board Member | 2015-12-31 | - |
Chief Executive Officer | 2015-12-31 | - | |
Founder | 2015-12-31 | - | |
The Biobreak Organization, Inc. | Director/Board Member | 2008-12-31 | - |
Praesidia Biotherapeutics, Inc.
Praesidia Biotherapeutics, Inc. Medical/Nursing ServicesHealth Services Praesidia Biotherapeutics, Inc. is a company that specializes in developing drugs using their proprietary Tunable Linker Technology called LESS (Linker Enzyme Substrate System). The company is based in Arlington, MA. This technology helps to maximize the therapeutic potential of drugs. The company was founded by Sohang Chatterjee, Pradip K. Majumder, and Santosh Kesari, with Sohang Chatterjee serving as the CEO since incorporation. | Director/Board Member | 2020-10-31 | - |
Independent Dir/Board Member | 2020-10-31 | - | |
CureDuchenne Ventures LLC
CureDuchenne Ventures LLC Investment ManagersFinance CureDuchenne Ventures LLC (CureDuchenne Ventures) is a venture capital subsidiary of CureDuchenne, founded in 2014 by Debra Miller. The firm is headquartered in Newport Beach, California. | Director/Board Member | 2019-04-30 | - |
Career history of Martin Lehr
Former positions of Martin Lehr
Companies | Position | Start | End |
---|---|---|---|
OUP Management Co. LLC
OUP Management Co. LLC Investment ManagersFinance OUP Management Co. LLC (Osage Partners) is a venture capital firm founded by Robert Adelson and Louis Berneman in 1990. The firm is headquartered in Bala Cynwyd, Pennsylvania. | Private Equity Analyst | 2009-08-12 | - |
Training of Martin Lehr
The Trustees of Columbia University in The City of New York | Graduate Degree |
University of Pennsylvania | Undergraduate Degree |
Statistics
International
United States | 9 |
Operational
Director/Board Member | 5 |
Chief Executive Officer | 2 |
Founder | 2 |
Sectoral
Finance | 3 |
Consumer Services | 3 |
Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
CONTEXT THERAPEUTICS INC. | Health Technology |
Private companies | 5 |
---|---|
OUP Management Co. LLC
OUP Management Co. LLC Investment ManagersFinance OUP Management Co. LLC (Osage Partners) is a venture capital firm founded by Robert Adelson and Louis Berneman in 1990. The firm is headquartered in Bala Cynwyd, Pennsylvania. | Finance |
Context Therapeutics LLC
Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Context Therapeutics LLC develops novel medicines for hormone responsive cancers. The company was founded by Martin Lehr in 2016 and is headquartered in Philadelphia, PA. | Health Technology |
The Biobreak Organization, Inc. | |
Praesidia Biotherapeutics, Inc.
Praesidia Biotherapeutics, Inc. Medical/Nursing ServicesHealth Services Praesidia Biotherapeutics, Inc. is a company that specializes in developing drugs using their proprietary Tunable Linker Technology called LESS (Linker Enzyme Substrate System). The company is based in Arlington, MA. This technology helps to maximize the therapeutic potential of drugs. The company was founded by Sohang Chatterjee, Pradip K. Majumder, and Santosh Kesari, with Sohang Chatterjee serving as the CEO since incorporation. | Health Services |
CureDuchenne Ventures LLC
CureDuchenne Ventures LLC Investment ManagersFinance CureDuchenne Ventures LLC (CureDuchenne Ventures) is a venture capital subsidiary of CureDuchenne, founded in 2014 by Debra Miller. The firm is headquartered in Newport Beach, California. | Finance |
- Stock Market
- Insiders
- Martin Lehr
- Experience